CA1159766A - Phthalazinol preparation - Google Patents

Phthalazinol preparation

Info

Publication number
CA1159766A
CA1159766A CA000363398A CA363398A CA1159766A CA 1159766 A CA1159766 A CA 1159766A CA 000363398 A CA000363398 A CA 000363398A CA 363398 A CA363398 A CA 363398A CA 1159766 A CA1159766 A CA 1159766A
Authority
CA
Canada
Prior art keywords
water
pharmaceutical composition
hydroxymethyl
dimethyl
phthalazone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000363398A
Other languages
English (en)
French (fr)
Inventor
Hiroshi Miyazaki
Yukiko Minatogawa
Hiroshi Ninomiya
Taka'aki Ohkuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
MSD KK
Original Assignee
Nippon Kayaku Co Ltd
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Co Ltd, Banyu Phamaceutical Co Ltd filed Critical Nippon Kayaku Co Ltd
Application granted granted Critical
Publication of CA1159766A publication Critical patent/CA1159766A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA000363398A 1979-11-07 1980-10-28 Phthalazinol preparation Expired CA1159766A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14339679A JPS5668609A (en) 1979-11-07 1979-11-07 Phthalazinol preparation
JP143396/1979 1979-11-07

Publications (1)

Publication Number Publication Date
CA1159766A true CA1159766A (en) 1984-01-03

Family

ID=15337783

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000363398A Expired CA1159766A (en) 1979-11-07 1980-10-28 Phthalazinol preparation

Country Status (7)

Country Link
US (1) US4406879A (enExample)
JP (1) JPS5668609A (enExample)
CA (1) CA1159766A (enExample)
DE (1) DE3041526A1 (enExample)
FR (1) FR2469181A1 (enExample)
GB (1) GB2062462B (enExample)
IT (1) IT8025835A0 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777048A (en) * 1983-07-07 1988-10-11 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
US4620974A (en) * 1983-07-07 1986-11-04 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
US4832952A (en) * 1983-07-07 1989-05-23 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1492034A1 (de) 1965-05-18 1969-02-20 Merck Ag E Verfahren zur Herstellung fester haltbarer Zubereitungen von empfindlichen,in Wasser schwer loeslichen Wirkstoffen,vorzugsweise Arzneimitteln
US3840662A (en) * 1971-08-05 1974-10-08 Shimamoto Takio Method of treating atherosclerosis using 4-hydroxymethyl-1-keto-1,2-dihydrophthalazine or acid salts thereof
ZA739543B (en) 1973-02-16 1975-03-26 Hoffmann La Roche Free-flowing, directly tablettable, pharmaceutically active substances
AR205004A1 (es) * 1973-10-30 1976-03-31 Ishikawa M Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
FR2377196A1 (fr) * 1977-01-13 1978-08-11 Lipha Composition medicamenteuse a usage oral
GB1579818A (en) 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity

Also Published As

Publication number Publication date
FR2469181A1 (fr) 1981-05-22
US4406879A (en) 1983-09-27
JPS5668609A (en) 1981-06-09
GB2062462A (en) 1981-05-28
IT8025835A0 (it) 1980-11-07
DE3041526A1 (de) 1981-05-21
GB2062462B (en) 1983-08-24
FR2469181B1 (enExample) 1984-01-06

Similar Documents

Publication Publication Date Title
US4389393A (en) Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
FI83037C (fi) Foerfarande foer framstaellning av en naproxen och natrium naproxentablett med styrd utloesning.
CA1331344C (en) Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
AU600950B2 (en) Controlled release dihydrocodeine composition
EP0965339B1 (en) Tabletted nateglinide preparation
KR940011242B1 (ko) 서방성 약제학적 제제의 제조방법
EP0251459B1 (en) Controlled release pharmaceutical composition
EP0157695B1 (en) Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US5211958A (en) Pharmaceutical composition and process for its preparation
CA1067827A (en) Apap tablet containing an alkali metal carboxymethylated starch and processes for manufacturing same
US4692337A (en) Sustained release pharmaceutical tablet of theophylline and production process thereof
CA2055905C (en) Pharmaceutical composition comprising calcium polycarbophil
EP0648116A1 (en) CONTROLLED RELEASE COMPOSITION OF AN ACTIVE SUBSTANCE AND PROCESS FOR PREPARING THE SAME.
EP0361354A1 (en) Dispersable dihydroergotoxin tablets
CA1159766A (en) Phthalazinol preparation
EP0255725A2 (en) Sustained-release multi-granule tablet
US5198228A (en) Direct dry compressible acetaminophen tablet
JPH0757726B2 (ja) 高分子量ヒドロキシプロピルメチルセルロースを基剤にした徐放性錠剤
JP3125221B2 (ja) ソファルコン含有固形製剤
IE903330A1 (en) An analgesic composition and a method for its formulation
AU657044B2 (en) Cytarabine ocfosfate hard capsule
CA1334933C (en) Pharmaceutical composition and process for its preparation
US5130140A (en) Method of making direct dry compressible acetaminophen composition
JP4221068B2 (ja) テオフィリン徐放性錠剤及びその製造方法
CN1546046A (zh) 阿德福韦酯分散片及其制备方法

Legal Events

Date Code Title Description
MKEX Expiry